EPS

(redirected from Extrapyramidal symptoms)
Also found in: Medical, Financial, Acronyms, Encyclopedia.

eps

abbreviation for
(Stock Exchange) earnings per share
Translations

EPS

abbr electrophysiology study. V. study.
References in periodicals archive ?
Studies suggest that older patients develop extrapyramidal symptoms with lower antipsychotic doses despite lower receptor occupancy
Symptoms following atypical antipsychotics include fewer extrapyramidal symptoms, reduced creatine kinase elevations, reduced muscle rigidity, and frequent mild fever.
showed similar efficacy of the two antipsychotics in reducing psychosis in PD but higher tendency of risperidone to worsen extrapyramidal symptoms [50].
Neurological symptoms mainly include extrapyramidal symptoms and neuropsychiatric symptoms.
Incidence and persistence of tardive dyskinesia and extrapyramidal symptoms in schizophrenia.
Manifestations of this increased sensitivity include confusion, obtundation, postural instability with frequent falls, extrapyramidal symptoms, and clinical features consistent with the neuroleptic malignant syndrome.
The OAP recommended quetiapine as the first-line treatment for secondary mania in a web-based HIV Psychiatry Treatment Consensus Survey in 2010, [sup][18] presumably because of its benign effects with regard to extrapyramidal symptoms for diseases prominently affecting the basal ganglia, such as Parkinson's disease [sup][19] or HIV illness.
f]-interval = Bazett's correction; EPSs = extrapyramidal symptoms.
Adult patients with schizophrenia: somnolence, akathisia, extrapyramidal symptoms, and nausea
At least there was no deterioration in UPDRS which reflect the extrapyramidal symptoms and parkinsonism after the treatment with yokukansan.
All antipsychotics studied carried some risk of side effects, most I notably weight gain and extrapyramidal symptoms that may include involuntary body or facial movements, extreme restlessness, a shuffling gait, or other disruptions in normal movement.
It should be noted that Fanapt has virtually no risk of akathisia and extrapyramidal symptoms, unlike Saphris or Latuda, which have demonstrated dose-related effects.

Full browser ?